Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price target decreased by TD Cowen from $10.00 to $9.00 in a research note issued to investors on Thursday morning,Benzinga reports.
Several equities research analysts recently weighed in on the company. Mizuho dropped their price target on Sage Therapeutics from $18.00 to $16.00 and set a “neutral” rating on the stock in a ...
Citi raised the firm’s price target on Sage Group (SGPYY) to 1,450 GBp from 1,350 GBp and keeps a Buy rating on the shares. Don't Miss our Black Friday Offers: Published first on TheFly – the ...
Barclays raised the firm’s price target on Sage Group (SGPYY) to 1,050 GBp from 970 GBp and keeps an Underweight rating on the shares. Unlock your investing potential with TipRanks Premium - Now ...
Morgan Stanley analyst Vikram Purohit lowered the firm’s price target on Sage Therapeutics (SAGE) to $9 from $11 and keeps an Equal Weight rating on the shares after its Q3 results last week.
Citi raised the firm’s price target on Sage Group (SGPYY) to 1,450 GBp from 1,350 GBp and keeps a Buy rating on the shares. TipRanks is the most comprehensive data set of sell side analysts and ...